Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital.

Slides:



Advertisements
Similar presentations
HELIOS Kliniken Leipziger Land Folie: 1 K. Kuhnt D. Schulz NESA DAYS 2006 Positive margins and early postop potency after Nerve-sparing ELRP Kai Kuhnt.
Advertisements

NPCA data collection on men undergoing radical surgery for prostate cancer Paul Cathcart, NPCA Urology Project Coordinator.
PROSTATE CANCER Dr Samad Zare Assistant Proffesor of Urology Shaheed Sadoughi University of Medical Sciences.
Advanced Stage Prostate Cancer Management Michael E. Karellas Assistant Professor of Urologic Oncology May 15, 2010.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Postoperative Radiation for Oral Cavity Squamous Cell Carcinoma: The EP.
Mr Jonathan Lewin MBBS, MRCS, MD, FRCS(Urol), FRACS Consultant Uro-Oncological Surgeon.
Radical Prostatectomy Sept 2009 till Aug 2010 South Mersey Cancer Network Manal Kumar Consultant Urologist.
PROSTATE CANCER EXPECTED MANAGEMENT & CURATIVE TREATMENT Dr. Abdullah A. Ghazi (R5) KSMC.
Prostate Radiotherapy A-Z
Everything you need to know about Prostate Radiotherapy During the talk or at end send QUESTIONS: Rob.
BIOLOGICAL PRINCIPLES OF BREAST CANCER TREAMENT Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University.
Management of Locally Advanced Rectal Cancer Joint Hospital Surgical Grand Round Pamela Youde Nethersole Eastern Hospital Dr. YH Ling 19 May 2007.
Treatment options for locally recurrent Prostate Cancer Giuseppe Simone Mediterranean School of Oncology Roma
Eleni Galani Medical Oncologist
Management of the Locoregional Recurrence in Well-differentiated Thyroid Carcinoma 陳漢文.
Prostate Cancer By: Kurt Rishel.
In the name of God Isfahan medical school Shahnaz Aram MD.
Failure of Treatment in Cervical Cancer Patients *Dr. Zohreh Yousefi fellow ship of gynecology oncology of Mashhad university Fatemeh Homaee, Marzieh.
Surrogate End point for Prostate Cancer- Specific Mortality After RP or EBRT A D’Amico J Nat Ca Inst 95,
T4 Colon Cancer and Laparoscopic Approach Gustavo Plasencia MD FACS, FASCRS Clinical Professor of Surgery Gustavo Plasencia MD FACS, FASCRS Clinical Professor.
Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.
Prostate Cancer Treatment: What’s Best For You?
Current Role of Partial Cystectomy: Are we scarifying patient ’ s survival Dr Eric Li Department of Surgery Pamela Youde Nethersole hospital.
Transanal Endoscopic Operation Indication – Technique – Results M. Sailer Department of Surgery Bethesda Hospital – Hamburg, Germany.
Protocols for Advanced Prostate Cancer and/or Local Failure After Radical Prostatectomy Isaac Powell, MD.
Prostate Cancer: Treatment choices Prostate Cancer: Treatment choices Winston W Tan MD FACP Winston W Tan MD FACP Senior Consultant Senior Consultant Genitourinary.
بسم الله الرحمن الرحيم. The role of three dimensional transrectal ultrasonography (3-D TRUS) and power Doppler sonography in prostatic lesions evaluation.
© Copyright Annals of Internal Medicine, 2009 Ann Int Med. 164 (1): ITC1-1. In the Clinic Prostate Cancer.
 T1 tumors at high risk of progression (high grade, multifocality, CIS, and tumor size, )  In all T1 patients failing intravesical therapy  muscle-invasive.
1 Prostate Cancer. 2 Prostate Gland Muscular Walnut-sized gland Makes seminal fluid Muscles contract to push semen through the urethra Located directly.
Prostatectomy operations in England South West Public Health Observatory Trends in the use of radical prostatectomy in England Sean McPhail.
Postsurgical Risk Factors for Prostate Cancer Mortality Slideset on: Freedland SJ, Humphreys EB, Mangold LA, et al. Risk of prostate cancer–specific mortality.
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer Anna Bill-Axelson, M.D., Lars Holmberg, M.D., Ph.D., Mirja Ruutu, M.D., Ph.D., Michael.
Carcinoma of the prostate. INTRODUCTION Prostate cancer is the most common cancer diagnosed and is the second leading cause of cancer death in men in.
Debulking in Ovarian Cancer Ashraf Fawzy Nabhan Assistant Prof. of Obstetrics & Gynecology Ain Shams University, Cairo, Egypt.
Journal Club August 10, 2012 Ryan M. Zitnay MD. Case 71 y/o male veteran w PMH CAD s/p MI, HTN, HL, constipation Followed by urology for rising PSA x.
Urology and male health
Robotic-assisted Laparoscopic Prostatectomy
International Neurourology Journal 2015;19:
Brain imaging prior to lung cancer resection
Carcinoma of Prostate Issam S. Al-Azzawi, MD,FICMS,FEBU By
Per-Anders Abrahamsson Department of Urology Malmö University Hospital
Group Issues Guidelines on Prostate Cancer Screening . . .
Liver surgery for metachronous hepatic metastases with uterine body and uterine cervix origin – a single center experience Nicolae Bacalbasa (1), Irina.
Volume 155, Issue 3, Pages (March 1996)
Surgical Treatment in Locally Advanced Prostate Cancer
Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital
Bladder Cancer and Prostatic Cancer
J. Edson PontesM.D. Professor Urologic Oncology WSU/KCI
Prostate cancer นพ.ชัชชัย หอมเกตุ.
Cervical Cancer Tiffany Smith HCP 102.
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Prognosis of younger patients in non-small cell lung cancer
Fig. 1c: Cystoprostatectomy specimen
Surgical Cancer Treatment
RTOG 0126 A Phase III Randomized Study of High Dose 3D-CRT/IMRT versus Standard Dose 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer Bijoy.
Prostrate Cancer Awareness Month September 2018 One Of The Most Lethal Cancers Amongst Men.
Post Op Positive Seminal Vesicle Case 4: Prostate_4
ROBOTIC ASSISSTED RADICAL PROSTATECTOMY OUR INITIAL EXPERIENCE
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
Apollo Gleneagles Hospitals,
Prostate Cancer Screening- Update
Volume 61, Issue 5, Pages (May 2012)
What is New in Hormone Therapy for Prostate Cancer in 2007?
External Beam Radiotherapy as Curative Treatment of Prostate Cancer
Neoadjuvant Adjuvant Curative Palliative
Fernando P. Secin, Fernando J. Bianco, Nicholas T
Assessment of Breast and Colorectal Cancer Surgery in Manitoba
Surgery for high-risk prostate cancer: The results of first 80 cases
Presentation transcript:

Professor Guram Karazanashvili MD, KMSc, DMSc MMT Hospital

When diagnosis of clinically locally advanced prostate cancer is established, patient selection and preparation for the surgery is critically important

Patient examination Experienced surgeon does DRE and TRUS DRE and TRUS are essential for estimation of resectability: Prostate consistence Prostate apex Lateral margins Adherence to rectum Seminal vesicles

Patient consultation How looks the patient? How motivated is he? Has the patient voiding problems? Take a time to explain the patient: -Different treatment modalities in context of quality of life and effectiveness -Necessity in adjuvant treatments -Speak with patient together with close relatives -Give patient a time for consideration

Patient selection  Good performance status  10 year survival should be expected  Patient motivated for aggressive cancer management  Patients ready for increased risk of incontinence and impotence

Preoperative evaluation and preparation Standardized preparation of patients for the surgery reduces the risks of intra and postoperative complications Special team is advisable for routine preoperative check up: Cardiologists, Anesthesiologist and urologist Send the patient for coronarography in any doubtful case Coronary stenting or bypass before surgery reduces the risks Hospitalization 1 day before the surgery Bowel preparation is needed, especially in locally advanced cases Anticoagulants night before surgery Gloves before surgery

Patients  Surgery from 2011 to 2014, by single surgeon  48 Patients with clinically locally advanced Prostate cancer were selected for the surgery T3a - 21patients T3b – 17 patients T4 – 8 patients

Patients DRE detected extra capsular spread Extra capsular spread was confirmed by TRUS, CT/MRI No balky lymph nodes by CT/MRI Bone scan was negative Patient age: years – 6 cases years – 21 cases years – 19 cases

Preoperative data  PSA < 30ng/ml  Gl cases  Gl. 7 (3+4) 5 cases  Gl. 7 (4+3) 16 cases  Gl. 8 6 cases  Gl.9 3 cases

Tipe of Surgery Radical prostatectomy with extended lymphadenectomy (along internal and external iliac vessels) – 38 cases Radical prostatectomy with bladder neck wide excision, and extended lymphadenectomy (along internal and external iliac vessels) – 4 cases Radical cystoprostatectomy, extended lymphadenectomy, sigma-rectum pouch – 1case Radical cystoprostatectomy, extended lymphadenectomy, ileal conduit (Briker’s operation) - 3 cases Monolateral or bilateral Nerve sparing – 24 cases

Surgical margins  Surgical margins were positive in 15 (of 46) patients: Apex 3 cases Neurovascular bundle 1 case Bladder neck 7 case Other locations 4 case  Relatively high incidence of positive margins at bladder neck was determined by preoperative downstaging and absence of macroscopic alterations intraoperatively

Stage migration Preoperative T stage migration occurred in 39% of cases: Downstaging 14 cases Overstaging5 cases Preoperative N stage migration occurred in 43% of cases: Downstaging 20 cases

Stage migration In 7 (of 12) downstaged men local spread reached T4 stage. These men need wide excision of bladder neck, beyond macroscopic alterations. 3 (of 5) T overstaged cases were node free. Thus surgery was curative 20 N downstaged men might benefit from lymphadenectomy

PSA > 0.2ng/ml at 3 monthes  N+ and positive surgical margins5 cases  N+4 cases  Positive surgical margins2 cases  N- and negative surgical margins2 cases  Overall in 28% of cases PSA>0.2ng/ml at 3 months, most of these patients are N+.  Only 7 (of 15) patients with positive surgical margins had PSA nadir above 0.2ng/ml. Thus despite residual tumor, prognosis can be favorable

Adjuvant therapies  Antiandrogens 4 cases  Medical or surgical castration 4 cases  Radiation therapy+medical castration 3 cases  No adjuvant therapies 35 cases

76% of patients with clinically locally advanced cases have got no adjuvant therapies!

Bone metastasis Currently 0 (of 46) patients have bone metastasis after surgery for clinically locally advanced prostate cancer

Incontinence At 3 monthes: Total incontinence 0 of (42) cases Stress incontinence 12 (of 42) cases Continent 30 (of 42) cases Currently: Total incontinence 0 (of 42) cases Stress incontinence 4 (of 42) cases Continent 38 (of 42) cases

Conclusions  Radical surgery is feasible in men with clinically locally advanced prostate cancer and should be applied in selected patients  Significant number of patients can be saved from adjuvant therapies  Surgical excision has potential to delay development of bone metastasis  Functional outcomes are excellent

Conclusions Node status downstaging, is common in cases of clinically locally advance prostate cancer patients Extended lymphadenectomy is recommended in all cases, this might have therapeutic results Bladder neck invasion is not rare, wide excision of bladder neck is recommended, even in case of absence of macroscopic alterations